Evidation Raises $153M in Series E Funding

Evidation Health

Evidation Health, a San Mateo, Calif.-based digital health company, closed a $153m Series E growth funding.

The round was co-led by Omers Growth Equity and Kaiser Permanente Group Trust with participation from existing investors McKesson Ventures and B Capital Group. Teresa Lee, Managing Director, Omers Growth Equity, joined Evidation’s Board of Directors.

The company intends to use the funds to accelerate the expansion of virtual health programs on the platform.

Led by Deborah Kilpatrick, PhD, Co-CEO and Executive Chair, Christine Lemke, Co-founder, Co-Chief Executive Officer, and President, and Luca Foschini, Co-founder & Chief Data Scientist, Achievement is a virtual health company that measures health in everyday life and enables anyone to participate in research and health programs. The company’s platform is used by millions of individuals, generating data with speed and scale.

To date, Evidation has conducted more than 100 real-world studies across therapeutic areas. In 2020, the company reached the milestone of more than 1 million individuals participating in research and health programs and expects to surpass 2 million later this year.